FrancophonIA/ELRC3.0 huggingface dataset:
English: Olanzapine for injection should not be combined in a syringe with diazepam injection because precipitation occurs when these products are mixed.
Slovenian: Olanzapina za injiciranje v brizgi ne smemo mešati z diazepamom za injiciranje, ker ob mešanju teh dveh zdravil pride do precipitacije.
English: Discard any unused contents.
Slovenian: Neporabljeno vsebino zavrzite.
English: Name and address of the manufacturer(s) responsible for batch release
Slovenian: A. IZDELOVALCI ZDRAVILA, ODGOVORNI ZA SPROŠČANJE SERIJ Ime in naslov izdelovalca (izdelovalcev), odgovornega (odgovornih) za sproščanje serij
English: (tablet coating) triacetin and indigo carmine colour (E132)
Slovenian: (obloga tablete) triacetin in barvilo indigotin (E132)
English: The efficacy of IM olanzapine has not been established in patients with agitation and disturbed behaviours related to conditions other than schizophrenia or manic episode.
Slovenian: olanzapina niso dokazali pri bolnikih z vznemirjenostjo in vedenjskimi motnjami, povezanimi z drugimi stanji in ne s shizofrenijo ali manično epizodo.
English: If you suddenly stop taking ZYPREXA, symptoms such as sweating, unable to sleep, tremor, anxiety or nausea and vomiting might occur.
Slovenian: Če nenadno prenehate jemati zdravilo ZYPREXA, se lahko pojavijo simptomi, kot so znojenje, nespečnost, tresenje, občutek tesnobe ali slabost in bruhanje.
English: Reconstitute ZYPREXA only with water for injections using standard aseptic techniques for reconstitution of parenteral products.
Slovenian: ZYPREXO pripravljajte samo z vodo za injekcije, upoštevaje standardne aseptične metode za pripravo zdravil za parenteralno uporabo.
English: Only take other medicines while you are on ZYPREXA if your doctor tells you that you can.
Slovenian: Med zdravljenjem z zdravilom ZYPREXA jemljite druga zdravila samo, če vam zdravnik pove, da smete.
English: ZYPREXA should be stored in its original pack in order to protect from light and moisture.
Slovenian: Zdravilo ZYPREXA shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo in vlago.
English: If you forget to take ZYPREXA Take your tablets as soon as you remember.
Slovenian: Vzemite tablete, kakor hitro se spomnite.
English: OTHER INGREDIENTS
Slovenian: DRUGI PODATKI
English: Inject into a vial of ZYPREXA.
Slovenian: Injicirajte v vialo ZYPREXE.
English: Uncommon (≥ 1/1,000 to < 1/100): Sinus pause.
Slovenian: Občasno (≥ 1/.,000 do < 1/100): Sinusni premor.
English: Withdraw 2.1 ml of water for injection into a sterile syringe.
Slovenian: Sterilno brizgo napolnite z 2,1 ml vode za injekcije.
English: • The other ingredients are - (tablet core) lactose monohydrate, hyprolose, crospovidone, microcrystalline cellulose, magnesium stearate and - (tablet coating) hypromellose, titanium dioxide (E171), carnauba wax.
Slovenian: - Pomožne snovi so (jedro tablete) laktoza monohidrat, hiproloza, krospovidon, mikrokristalna celuloza, magnezijev stearat in (obloga tablete) hipromeloza, titanov dioksid (E171), karnauba vosek.
English: What ZYPREXA Injection contains
Slovenian: DODATNE INFORMACIJE Kaj vsebuje ZYPREXA injekcija
English: Common side effects (may affect up to 1 in 10 people) with ZYPREXA Injection include slower or faster heart rate; sleepiness; low blood pressure; discomfort at the site of injection.
Slovenian: Pogosti neželeni učinki (lahko prizadenejo več kot 1 od 10 bolnikov) pri zdravilu ZYPREXA injekcija vključujejo počasnejši ali hitrejši srčni utrip, zaspanost, nizek krvni tlak, občutek neugodja na mestu injiciranja.
English: In one clinical trial in patients with bipolar mania, valproate combination therapy with olanzapine resulted in an incidence of neutropenia of 4.1 %; a potential contributing factor could be high plasma valproate levels.
Slovenian: V enem kliničnem preskušanju pri bolnikih z bipolarno manijo, je kombinirano zdravljenje z valproatom in olanzapinom povzročila incidenco nevtropenije 4,1 %; možen vzročni dejavnik so lahko visoke plazemske ravni valproata.
English: Other very common side effects (may affect more than 1 in 10 people) include weight gain; and increases in levels of prolactin in the blood.
Slovenian: Drugi zelo pogosti neželeni učinki (lahko prizadenejo več kot 1 od 10 bolnikov) vključujejo povečanje telesne mase in povišanje ravni prolaktina v krvi.
English: As a routine precaution, if you are over 65 years your doctor may monitor your blood pressure.
Slovenian: Kot običajen previdnostni ukrep vam lahko vaš zdravnik nadzoruje krvni tlak, če ste stari več kot
English: If the patient is considered to need parenteral benzodiazepine treatment, this should not be given until at least one hour after IM olanzapine administration.
Slovenian: Če bi bolnik potreboval zdravljenje s parenteralnim benzodiazepinom, mu tega ne smemo dati, dokler od dajanja i.m.
English: Single use vial.
Slovenian: Viala za enkratno uporabo.
English: For intramuscular use.
Slovenian: Odrasli Za intramuskularno uporabo.
English: Do not drink any alcohol if you have been given ZYPREXA as together with alcohol it may make you feel drowsy.
Slovenian: Če ste dobili zdravilo ZYPREXA, ne pijte nobenega alkohola, saj lahko zdravilo ZYPREXA in alkohol skupaj povzročita občutek zaspanosti.
English: Reconstitute ZYPREXA Powder for Solution for Injection using standard aseptic techniques for reconstitution of parenteral products.
Slovenian: ZYPREXA prašek za raztopino za injiciranje pripravite z uporabo standardnih aseptičnih metod za pripravo zdravil za parenteralno uporabo.
English: Thromboembolism (including pulmonary embolism and deep vein thrombosis) (see section 4.4)
Slovenian: (vključno s pljučno embolijo in globoko vensko trombozo) (glejte poglavje 4.4)
English: Elevated cholesterol levels2,3 Elevated glucose levels4
Slovenian: Zvišane ravni holesterola2,3 Zvišane ravni glukoze4
English: In placebocontrolled clinical trials (6-12 weeks duration) of elderly patients (mean age 78 years) with dementiarelated psychosis and/or disturbed behaviours, there was a 2-fold increase in the incidence of death in olanzapine-treated patients compared to patients treated with placebo (3.5 % vs. 1.5 %, respectively).
Slovenian: povezano z demenco in/ali vedenjskimi motnjami (povprečna starost 78 let), je bilo 2-kratno povečanje incidence smrti pri bolnikih, zdravljenih z olanzapinom, v primerjavi z bolniki, zdravljenimi s placebom (3,5 % v primerjavi z 1,5 %).
English: ZYPREXA powder for solution for injection is not recommended for use in children and adolescents due to a lack of data on safety and efficacy.
Slovenian: Izkušenj pri otrocih ni. Zaradi pomanjkanja podatkov o varnosti in učinkovitosti uporaba ZYPREXA praška za raztopino za injiciranje pri otrocih in mladostnikih ni priporočena.
English: Each ZYPREXA tablet contains either 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg or 20 mg of the active substance.
Slovenian: Ena ZYPREXA tableta vsebuje 2,5 mg, 5 mg, 7,5 mg, 10 mg, 15 mg ali 20 mg zdravilne učinkovine.
English: ZYPREXA 15 mg coated tablets are blue.
Slovenian: ZYPREXA 15 mg obložene tablete so modre.
English: Coated Tablets Lilly S.A., Avda.
Slovenian: Obložene tablete Lilly S.A., Avda.
English: If the patient has received parenteral benzodiazepine, IM olanzapine administration should only be considered after careful evaluation of clinical status and the patient should be closely monitored for excessive sedation and cardiorespiratory depression.
Slovenian: olanzapina razmišljamo šele po skrbni oceni kliničnega stanja, bolnika pa moramo tudi natančno spremljati zaradi možnosti čezmerne sedacije in kardiorespiratorne depresije.
English: Gynaecomastia/breast enlargement in males
Slovenian: Ginekomastija/pov ečanje dojk pri moških
English: Package leaflet: Information for the user ZYPREXA 10 mg powder for solution for injection Olanzapine
Slovenian: Navodilo za uporabo: informacije za uporabnika ZYPREXA 10 mg prašek za raztopino za injiciranje olanzapin
English: Your doctor or nurse will make it up into a solution.
Slovenian: Vaš zdravnik ali medicinska sestra bo pripravil iz praška raztopino.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON OF COATED TABLETS IN BLISTERS
Slovenian: PODATKI NA ZUNANJI OVOJNINI ŠKATLA Z OBLOŽENIMI TABLETAMI V PRETISNIH OMOTIH
English: LIST OF EXCIPIENTS Lactose monohydrate, tartaric acid, hydrochloric acid, sodium hydroxide
Slovenian: SEZNAM POMOŽNIH SNOVI Laktoza monohidrat, vinska kislina, klorovodikova kislina, natrijev hidroksid.
English: During treatment with olanzapine in combination with lithium or divalproex, an increase of ≥ 7 % from baseline body weight occurred in 17.4 % of patients during acute treatment (up to 6 weeks).
Slovenian: Med zdravljenjem z olanzapinom v kombinaciji z litijem ali divalproeksom se je pri 17,4 % bolnikov med akutnim zdravljenjem ( do 6 tednov) pojavilo povečanje telesne mase za > 7 % z osnove.
English: In clinical trials, clinically meaningful QTc prolongations (Fridericia QT correction [QTcF] ≥ 500 milliseconds [msec] at any time post baseline in patients with baseline QTcF < 500 msec) were uncommon (0.1 % to 1 %) in patients treated with olanzapine, with no significant differences in associated cardiac events compared to placebo.
Slovenian: [QTcF] ≥ 500 milisekund [msek] kadarkoli nad osnovno vrednostjo pri bolnikih z osnovno vrednostjo QTcF < 500 msek) pri bolnikih, zdravljenih z olanzapinom, redka (od 0,1 % do 1 %), brez pomembnih razlik v spremljajočih srčnih dogodkih v primerjavi z bolniki, zdravljenimi s placebom.
English: 1 vial EU/1/96/022/017 - ZYPREXA - Powder for solution for injection.
Slovenian: 1 viala EU/1/96/022/017 - ZYPREXA - Prašek za raztopino za injiciranje.
English: In renally impaired patients (creatinine clearance < 10 ml/min) versus healthy subjects, there was no significant difference in mean elimination half-life (37.7 versus 32.4 hr) or clearance (21.2 versus 25.0 l/hr).
Slovenian: Po dajanju peroralnega olanzapina bolnikom z okvarjenim delovanjem ledvic (očistek kreatinina < 10 ml/min) v primerjavi z zdravimi osebami ni bilo značilne razlike v srednjem razpolovnem času izločanja (37,7 v primerjavi z 32,4 ure) ali očistku (21,2 v primerjavi s 25,0 l/h).
English: While olanzapine demonstrated anticholinergic activity in vitro, experience during oral clinical trials revealed a low incidence of related events.
Slovenian: Antiholinergično delovanje Medtem ko je olanzapin pokazal antiholinergično delovanje v pogojih in vitro, so izkušnje kliničnih preskušanj peroralnega olanzapina razkrile majhno incidenco s tem povezanih dogodkov.
English: With long-term exposure (at least 24 weeks), 89.4 % gained ≥ 7 %, 55.3 % gained ≥ 15 % and 29.1 % gained ≥ 25 % of their baseline body weight.
Slovenian: Pri dolgoročni izpostavljenosti (najmanj 24 tednov) jih je 89,4 % pridobilo ≥ 7 %,
English: Other symptoms may be: acute confusion, seizures (epilepsy), coma, a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness, slowing of the breathing rate, aspiration, high blood pressure or low blood pressure, abnormal rhythms of the heart.
Slovenian: Drugi simptomi so vključujejo: akutno zmedenost, krče (epilepsijo), komo, kombinacijo zvišane telesne temperature, hitrega dihanja, znojenja, okorelosti mišic in omotičnosti ali zaspanosti, upočasnjeno dihanje, aspiracijo, visok krvni tlak ali nizek krvni tlak, motnje srčnega ritma.
English: ZYPREXA 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg coated tablets 3 years.
Slovenian: ZYPREXA 5 mg, 7,5 mg, 10 mg, 15 mg in 20 mg obložene tablete
English: ZYPREXA 20 mg coated tablets are pink.
Slovenian: ZYPREXA 20 mg obložene tablete so rožnate.
English: Crospovidone Microcrystalline cellulose Magnesium stearate
Slovenian: Jedro tablete laktoza monohidrat hiproloza krospovidon mikrokristalna celuloza magnezijev stearat
English: ZYPREXA 2.5 mg coated tablets ZYPREXA 5 mg coated tablets ZYPREXA 7.5 mg coated tablets ZYPREXA 10 mg coated tablets ZYPREXA 15 mg coated tablets ZYPREXA 20 mg coated tablets
Slovenian: ZYPREXA 2,5 mg obložene tablete ZYPREXA 5 mg obložene tablete ZYPREXA 7,5 mg obložene tablete ZYPREXA 10 mg obložene tablete ZYPREXA 15 mg obložene tablete ZYPREXA 20 mg obložene tablete
English: ZYPREXA 2.5 mg coated tablets ZYPREXA 5 mg coated tablets ZYPREXA 7.5 mg coated tablets ZYPREXA 10 mg coated tablets ZYPREXA 15 mg coated tablets ZYPREXA 20 mg coated tablets Olanzapine
Slovenian: ZYPREXA 2,5 mg obložene tablete ZYPREXA 5 mg obložene tablete ZYPREXA 7,5 mg obložene tablete ZYPREXA 10 mg obložene tablete ZYPREXA 15 mg obložene tablete ZYPREXA 20 mg obložene tablete olanzapin
English: Each vial contains 10 mg of the active substance.
Slovenian: Ena viala vsebuje 10 mg zdravilne učinkovine.
English: MARKETING AUTHORISATION NUMBER (S) EU/1/96/022/016 Powder for solution for injection.
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/96/022/016 Prašek za raztopino za injiciranje.
English: Very common side effects (may affect more than 1 in 10 people) include weight gain; sleepiness; and increases in levels of prolactin in the blood.
Slovenian: Zelo pogosti neželeni učinki (lahko prizadenejo več kot 1 od 10 bolnikov) vključujejo povečanje telesne mase, zaspanost in povišanje ravni prolaktina v krvi.
English: • High blood sugar and high levels of fat (triglycerides and cholesterol) have been seen in patients taking ZYPREXA.
Slovenian: • Pri bolnikih, ki so jemali zdravilo ZYPREXA, so opazili visok nivo sladkorja v krvi in visok nivo maščob (trigliceridov in holesterola).
English: • The other ingredients are lactose monohydrate, tartaric acid, hydrochloric acid and sodium hydroxide.
Slovenian: - Pomožne snovi so laktoza monohidrat, vinska kislina, klorovodikova kislina in natrijev hidroksid.
English: Transient, asymptomatic elevations of hepatic aminotransferases, ALT, AST have been seen commonly, especially in early treatment.
Slovenian: Pogosto so opažali prehodna, asimptomatska zvišanja jetrnih aminotransferaz, ALT in AST, posebno na začetku zdravljenja.
English: How to take ZYPREXA
Slovenian: Kako jemati zdravilo ZYPREXA
English: Depending on the patient's clinical status (see section 4.4), a second injection, 2.5 - 5 mg, may be administered 2 hours after the first injection.
Slovenian: Priporočeni začetni odmerek pri starejših bolnikih (> 60 let) je 2,5-5 mg. Glede na bolnikovo klinično stanje (glejte poglavje 4.4) lahko damo drugo injekcijo, 2,5-5 mg, 2 uri po prvi.
English: Signs of oral toxicity in rodents were characteristic of potent antipsychotic compounds: hypoactivity, coma, tremors, clonic convulsions, salivation, and depressed weight gain.
Slovenian: Akutna toksičnost (toksičnost po enkratnem odmerku) Znaki toksičnosti po peroralnem dajanju pri glodavcih so bili značilni za močne antipsihotike: hipoaktivnost, koma, tresenje, klonični krči, slinjenje in zmanjšano pridobivanje telesne mase.
English: ZYPREXA comes as a powder.
Slovenian: Zdravilo ZYPREXA je na voljo kot prašek.
English: High Gamma Glutamyltransferase10
Slovenian: Visoka raven gamaglutamiltransferaz e10
English: 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) was very common (40.6 %), ≥ 15 % of baseline body weight was common (7.1 %) and ≥ 25 % was common (2.5 %).
Slovenian: 13 S kratkotrajnim zdravljenjem (srednje trajanje 22 dni) povezano povečanje telesne mase za ≥ 7 % od osnovne telesne mase (kg) je bilo zelo pogosto (40,6 %), ≥ 15 % pogosto (7,1 %) in za ≥ 25 %
English: Patients who have taken more ZYPREXA than they should have experienced the following symptoms: rapid beating of the heart, agitation/aggressiveness, problems with speech, unusual movements (especially of the face or tongue) and reduced level of consciousness.
Slovenian: hitro bitje srca, vznemirjenost/nasilnost, težave pri govoru, nenavadne zgibke (posebno v mišicah obraza ali jezika) in zmanjšano stopnjo zavesti.
English: Potential for olanzapine to affect other medicinal products Olanzapine may antagonise the effects of direct and indirect dopamine agonists (see section 6.2).
Slovenian: Olanzapin lahko nasprotuje učinkom direktnih in indirektnih dopaminskih agonistov (glejte poglavje
English: Powder for Solution for Injection
Slovenian: Prašek za raztopino za injiciranje
English: 8 In clinical trials of up to 12 weeks, plasma prolactin concentrations exceeded the upper limit of normal range in approximately 30% of olanzapine treated patients with normal baseline prolactin value.
Slovenian: 8 V kliničnih preskušanjih, ki so trajala do 12 tednov, so pri 30 % bolnikov z normalno začetno vrednostjo prolaktina, ki so se zdravili z olanzapinom, ugotovili zvišanje plazemske koncentracije prolaktina nad zgornjo mejo normalne vrednosti.
English: Colour mixture light blue (titanium dioxide E171, lactose monohydrate, hypromellose, triacetin, indigo carmine colour (E132))
Slovenian: ZYPREXA 15 mg obložene tablete hipromeloza zmes svetlo modrega barvila (titanov dioksid E171, laktoza monohidrat, hipromeloza, triacetin, indigotin (E132)) karnauba vosek
English: Rare side effects (may affect up to 1 in 1000 people) include lowering of normal body temperature; abnormal rhythms of the heart; sudden unexplained death; inflammation of the pancreas causing severe stomach pain, fever and sickness; liver disease appearing as yellowing of the skin and white parts of the eyes; muscle disease presenting as unexplained aches and pains; and prolonged and/or painful erection.
Slovenian: Redki neželeni učinki (lahko prizadenejo do 1 od 1.000 bolnikov) vključujejo znižanje normalne telesne temperature, motnje srčnega ritma, nenadno nerazložljivo smrt, vnetje trebušne slinavke, ki povzroča hude bolečine v predelu želodca, zvišano telesno temperaturo in slabost, obolenje jeter, ki se kaže kot obarvanje kože in beločnic na rumeno, mišične bolezni, ki se kažejo kot nerazložljive bolečinske težave in bolečine ter podaljšano in/ali bolečo erekcijo.
English: ZYPREXA contains the active substance olanzapine.
Slovenian: Zdravilo ZYPREXA vsebuje zdravilno učinkovino olanzapin.
English: In comparator oral studies of one year or less duration, olanzapine was associated with a statistically significant lower incidence of treatment emergent dyskinesia.
Slovenian: Tardivne diskinezije V primerjalnih študijah peroralnega olanzapina, ki so trajale eno leto ali manj, so olanzapin povezovali s statistično značilno manjšo incidenco diskinezij, ki se pojavijo ob zdravljenju.
English: TABLET STRENGTH
Slovenian: JAKOST TABLET
English: DRESS appears initially as flu-like symptoms with a rash on the face and then with an extended rash, high temperature, enlarged lymph nodes, increased levels of liver enzymes seen on blood tests and an increase in a type of white blood cells (eosinophilia).
Slovenian: povečanimi bezgavkami, povišanimi ravnmi jetrnih encimov na izvidih krvnih testov in s povišanjem vrste belih krvničk (eozinofilija).
English: Dystonia (including oculogyration)11
Slovenian: Distonija (vključno z okulogiracijo)11 Tardivne diskinezije11
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 10 mg powder for solution for injection
Slovenian: IME ZDRAVILA ZYPREXA 10 mg prašek za raztopino za injiciranje
English: Warnings and precautions Talk to your doctor or nurse before you are given ZYPREXA Injection
Slovenian: Opozorila in previdnostni ukrepi Pred začetkom jemanja zdravila ZYPREXA se posvetujte s svojim zdravnikom ali s farmacevtom.
English: 8 In clinical trials of up to 12 weeks, plasma prolactin concentrations exceeded the upper limit of normal range in approximately 30 % of olanzapine treated patients with normal baseline prolactin value.
Slovenian: 8V kliničnih preskušanjih, ki so trajala do 12 tednov, so pri 30 % bolnikov z normalno začetno vrednostjo prolaktina, ki so se zdravili z olanzapinom, ugotovili zvišanje plazemske koncentracije prolaktina nad zgornjo mejo normalne vrednosti.
English: ZYPREXA 20 mg tablets
Slovenian: ZYPREXA 20 mg tablete
English: INFORMATION IN BRAILLE ZYPREXA 20 mg
Slovenian: PODATKI V BRAILLOVI PISAVI ZYPREXA 20 mg
English: What ZYPREXA looks like and contents of the pack ZYPREXA 2.5 mg coated tablets are white imprinted with “LILLY” and a numeric identicode “4112”.
Slovenian: Izgled zdravila ZYPREXA in vsebina pakiranja ZYPREXA 2,5 mg obložene tablete so bele ter imajo natisnjeno oznako »LILLY« in numerično identifikacijo »4112«.
English: INFORMATION IN BRAILLE ZYPREXA 7.5 mg
Slovenian: PODATKI V BRAILLOVI PISAVI ZYPREXA 7,5 mg
English: Colour mixture pink (titanium dioxide E171, macrogol, lactose monohydrate, hypromellose, synthetic red iron oxide)
Slovenian: ZYPREXA 20 mg obložene tablete hipromeloza zmes rožnatega barvila (titanov dioksid E171, makrogol, laktoza monohidrat, hipromeloza, sintetični rdeči železov oksid)
English: Only take other medicines while you are on ZYPREXA if your doctor tells you that you can. You might feel drowsy if ZYPREXA is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers).
Slovenian: Če jemljete zdravilo ZYPREXA v kombinaciji z zdravili za zdravljenje depresije, zdravili za zdravljenje občutkov tesnobe ali zdravili, ki vam pomagajo spati (pomirjevala), se lahko počutite zaspani.
English: Hepatitis (including hepatocellular, cholestatic or mixed liver injury)11
Slovenian: (vključno s hepatocelularno, holestatsko ali mešano okvaro jeter)11
English: Powder for Solution for Injection.
Slovenian: Prašek za raztopino za injiciranje.
English: - If you get any side effects talk to your doctor or nurse.
Slovenian: - Če opazite katerikoli neželeni učinek, se posvetujte s svojim zdravnikom ali z medicinsko sestro.
English: • Weight gain has been seen in patients taking ZYPREXA.
Slovenian: • Pri bolnikih, ki so jemali zdravilo ZYPREXA, so opazili porast telesne mase.
English: METHOD OF ADMINISTRATION Read the package leaflet before use
Slovenian: POSTOPEK UPORABE ZDRAVILA Pred uporabo preberite priloženo navodilo!
English: ZYPREXA 7.5 mg coated tablets
Slovenian: ZYPREXA 7,5 mg obložene tablete
English: ZYPREXA 15 mg tablets
Slovenian: ZYPREXA 15 mg tablete
English: Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements(dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
Slovenian: Pogosti neželeni učinki (lahko prizadenejo do 1 od 10 bolnikov) vključujejo spremembe v ravneh nekaterih krvnih celic, maščob v krvnem obtoku in v začetnih obdobjih zdravljenja, začasno povišanje jetrnih encimov, zvišanja v ravni sladkorjev v krvi in urinu, zvišanja v ravni sečne kisline in kreatinfosfokinaze v krvi, večji občutek lakote, omotico, nemirnost, tresenje, nenavadne gibe (diskinezijo), zaprtje, suha usta, izpuščaj, izgubo moči, hudo utrujenost, zadrževanje vode, ki vodi v otekanje rok, gležnjev ali nog, vročino, bolečine v sklepih ter spolne disfunkcije, kot na primer zmanjšan libido pri moških in ženskah ter erektilna disfunkcija pri moških.
English: Elevated triglyceride levels2,5 Glucosuria Increased appetite
Slovenian: Zvišane ravni trigliceridov2,5 Glikozurija
English: Tardive dyskinesia11
Slovenian: Disartrija Jecljanje11
English: In addition, the following side effects have been seen after patients have taken ZYPREXA orally.
Slovenian: Poleg tega so pri bolnikih, ki so zdravilo ZYPREXA jemali peroralno, poročali o naslednjih neželenih učinkih.
English: Discard syringe and unused solution appropriately
Slovenian: Brizgo in neuporabljeno raztopino zavrzite v skladu s predpisi.